Ebola vaccine

He said there were no side effects.
Djerlek told RTS that among the noticed consequences of the vaccine were redness of the place where the vaccine was applied, pain at the puncture place and a temperature of 37.2, which passed within a few hours.
"I would like us to continue like this," Djerlek said.

Volunteers for trials of the coronavirus vaccine in Turkey are being closely monitored at every stage, according to authorities.

The phase-3 trials of the Chinese COVID-19 vaccine which began on Sept. 15 are ongoing in two stages.

They include high-risk health care workers and medium-risk volunteers, according to information received by Anadolu Agency.

Tests on a Turkish-made coronavirus vaccine are going smoothly, with none of the volunteers testing the vaccine showing any side effects, said the rector of a university in central Turkey on Nov. 23. 

Mustafa Çalış, the rector of Erciyes University in the Kayseri province, said 44 volunteers have been testing the ERUCOV-VAC vaccine.

A prototype vaccine for Ebola may be "up to 100 percent effective" in protecting against the deadly virus, the World Health Organization (WHO) said Dec. 23.

The latest in a string of candidate vaccines against the deadly Ebola virus was proven safe in an early trial in healthy adults in China, its developers said Wednesday.
      
But while it triggered an antibody response in test subjects, further trials must be held to establish whether the drug actually protects against Ebola, they said.
      

The first large-scale trial of an Ebola vaccine will begin in Guinea at the weekend, the World Health Organization said March 5, weeks after a similar test kicked off in neighbouring Liberia.
      

Human tests of two possible Ebola vaccines have proven safe and efficacy tests will begin within weeks in the three west African countries ravaged by the deadly virus, the World Health Organization said Jan. 9.
      

An experimental Ebola vaccine appears safe and triggered signs of immune protection in the first 20 volunteers to test it, U.S. researchers reported Nov. 26.